CAMP4 Therapeutics Corporation
NASDAQ:CAMPBiotechnology
+$0.10 today
- Market cap
- $251.02M
- Beta
- 0.08
- P/E (TTM)
- -2.8
- EPS (TTM)
- -$1.49
Volume 0.21M
Average 0.10M
Balance Sheet
Inspect the capital base behind the business.
Assets
$117.81M
FY 2025 · Annual
+50.4% YoYLiabilities
$70.10M
FY 2025 · Annual
+362.3% YoYEquity
$47.70M
FY 2025 · Annual
-24.5% YoYBalance Sheet
Metric | FY2021 Feb 2022 | FY2022 Feb 2023 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 91.11M | 83.19M | 38.38M | 64.04M | 109.52M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 58.59M | 678K | 442K | 108K | 155K |
| Inventory | 20.18M | 0 | 0 | 0 | 0 |
| Other Current Assets | 23.71M | 205K | 245K | 211K | 4.42M |
| Total Current Assets | 193.59M | 84.41M | 40.01M | 66.38M | 114.1M |
| Property, Plant & Equipment (Net) | 50.06M | 16.8M | 13.31M | 10.3M | 2.74M |
| Goodwill | 94M | 0 | 0 | 0 | 0 |
| Intangible Assets | 33.01M | 0 | 0 | 0 | 0 |
| Long-term Investments | 24.34M | 0 | 0 | 0 | 894K |
| Tax Assets | 4.23M | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3.05M | 1.35M | 1.62M | 1.62M | 83K |
| Total Non-current Assets | 208.7M | 18.14M | 14.93M | 11.92M | 3.71M |
| Total Assets | 402.29M | 102.55M | 54.95M | 78.31M | 117.81M |
| Account Payables | 30.78M | 2.15M | 1.04M | 1.21M | 182K |
| Short-term Debt | 7.74M | 0 | 0 | 0 | 286K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 32.4M | 0 | 0 | 385K | 9.39M |
| Other Current Liabilities | 23.96M | 1.78M | 2.34M | 3.2M | 5.66M |
| Total Current Liabilities | 94.88M | 7.95M | 7.81M | 9.6M | 15.51M |
| Long-term Debt | 201.43M | 0 | 0 | 0 | 1.69M |
| Deferred Tax Liabilities | 208K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 14.49M | 0 | 0 | 0 | 8.11M |
| Other Non-current Liabilities | 11.1M | 162.11M | 162.23M | 2K | 44.79M |
| Total Non-current Liabilities | 227.23M | 172.13M | 170.87M | 5.57M | 54.59M |
| Total Liabilities | 322.11M | 180.08M | 178.68M | 15.16M | 70.1M |
| Common Stock | 359K | 1K | 1K | 2K | 6K |
| Retained Earnings | (156.78M) | (110.67M) | (159.96M) | (211.75M) | (292.16M) |
| Accumulated OCI | (2.44M) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 239.04M | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 80.18M | (77.53M) | (123.73M) | 63.14M | 47.7M |
| Total Debt | 209.17M | 12.4M | 11.69M | 8.65M | 1.97M |
| Net Debt | 118.05M | (70.8M) | (26.69M) | (55.39M) | (107.54M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $99.2M |
| Other Current | $3.0M |
| Total Current Assets | $102.2M |
| PP&E (Net) | $2.3M |
| Other Non-current | $970.0K |
| Total Non-current Assets | $3.3M |
| Total Assets | $105.5M |
Analysis
Selected assets total $105.5M for Latest. The largest visible component is Cash & Equivalents at $99.2M, about 94.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 |
How much cash does CAMP have?
CAMP4 Therapeutics Corporation (CAMP) reported $109.52M in cash and equivalents in fiscal 2025.
How much debt does CAMP carry?
CAMP4 Therapeutics Corporation (CAMP) reported $1.97M of total debt, with net debt of -$107.54M.
Continue the stock analysis
Jump to another research area for this company.